Chengjian Zhao1,2, Joseph J Lancman1, Yi Yang2, Keith P Gates1, Dan Cao2, Lindsey Barske3, Jonathan Matalonga1, Xiangyu Pan2, Jiaye He4, Alyssa Graves4, Jan Huisken4,5, Chong Chen2, P Duc Si Dong1,6. 1. Human Genetics Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA. 2. State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Sichuan, People's Republic of China. 3. Department of Pediatrics, College of Medicine & Division of Human Genetics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA. 4. Morgridge Institute for Research, Madison, Wisconsin, USA. 5. Department of Integrative Biology, University of Wisconsin-Madison, Madison, Wisconsin, USA. 6. Graduate School of Biomedical Sciences, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Abstract
BACKGROUND AND AIMS: Alagille Syndrome (ALGS) is a congenital disorder caused by mutations in the Notch ligand gene JAGGED1, leading to neonatal loss of intrahepatic duct (IHD) cells and cholestasis. Cholestasis can resolve in certain patients with ALGS, suggesting regeneration of IHD cells. However, the mechanisms driving IHD cell regeneration following Jagged loss remains unclear. Here, we show that cholestasis due to developmental loss of IHD cells can be consistently phenocopied in zebrafish with compound jagged1b and jagged2b mutations or knockdown. APPROACH AND RESULTS: Leveraging the transience of jagged knockdown in juvenile zebrafish, we find that resumption of Jagged expression leads to robust regeneration of IHD cells through a Notch-dependent mechanism. Combining multiple lineage tracing strategies with whole-liver three-dimensional imaging, we demonstrate that the extrahepatic duct (EHD) is the primary source of multipotent progenitors that contribute to the regeneration, but not to the development, of IHD cells. Hepatocyte-to-IHD cell transdifferentiation is possible but rarely detected. Progenitors in the EHD proliferate and migrate into the liver with Notch signaling loss and differentiate into IHD cells if Notch signaling increases. Tissue-specific mosaic analysis with an inducible dominant-negative Fgf receptor suggests that Fgf signaling from the surrounding mesenchymal cells maintains this extrahepatic niche by directly preventing premature differentiation and allocation of EHD progenitors to the liver. Indeed, transcriptional profiling and functional analysis of adult mouse EHD organoids uncover their distinct differentiation and proliferative potential relative to IHD organoids. CONCLUSIONS: Our data show that IHD cells regenerate upon resumption of Jagged/Notch signaling, from multipotent progenitors originating from an Fgf-dependent extrahepatic stem cell niche. We posit that if Jagged/Notch signaling is augmented, through normal stochastic variation, gene therapy, or a Notch agonist, regeneration of IHD cells in patients with ALGS may be enhanced.
BACKGROUND AND AIMS: Alagille Syndrome (ALGS) is a congenital disorder caused by mutations in the Notch ligand gene JAGGED1, leading to neonatal loss of intrahepatic duct (IHD) cells and cholestasis. Cholestasis can resolve in certain patients with ALGS, suggesting regeneration of IHD cells. However, the mechanisms driving IHD cell regeneration following Jagged loss remains unclear. Here, we show that cholestasis due to developmental loss of IHD cells can be consistently phenocopied in zebrafish with compound jagged1b and jagged2b mutations or knockdown. APPROACH AND RESULTS: Leveraging the transience of jagged knockdown in juvenile zebrafish, we find that resumption of Jagged expression leads to robust regeneration of IHD cells through a Notch-dependent mechanism. Combining multiple lineage tracing strategies with whole-liver three-dimensional imaging, we demonstrate that the extrahepatic duct (EHD) is the primary source of multipotent progenitors that contribute to the regeneration, but not to the development, of IHD cells. Hepatocyte-to-IHD cell transdifferentiation is possible but rarely detected. Progenitors in the EHD proliferate and migrate into the liver with Notch signaling loss and differentiate into IHD cells if Notch signaling increases. Tissue-specific mosaic analysis with an inducible dominant-negative Fgf receptor suggests that Fgf signaling from the surrounding mesenchymal cells maintains this extrahepatic niche by directly preventing premature differentiation and allocation of EHD progenitors to the liver. Indeed, transcriptional profiling and functional analysis of adult mouse EHD organoids uncover their distinct differentiation and proliferative potential relative to IHD organoids. CONCLUSIONS: Our data show that IHD cells regenerate upon resumption of Jagged/Notch signaling, from multipotent progenitors originating from an Fgf-dependent extrahepatic stem cell niche. We posit that if Jagged/Notch signaling is augmented, through normal stochastic variation, gene therapy, or a Notch agonist, regeneration of IHD cells in patients with ALGS may be enhanced.
Authors: P Duc Si Dong; Chantilly A Munson; William Norton; Cecile Crosnier; Xiufang Pan; Zhiyuan Gong; Carl J Neumann; Didier Y R Stainier Journal: Nat Genet Date: 2007-01-28 Impact factor: 38.330
Authors: Marialena Mouzaki; Lee M Bass; Ronald J Sokol; David A Piccoli; Claudia Quammie; Kathleen M Loomes; James E Heubi; Paula M Hertel; Rene Scheenstra; Katryn Furuya; Erika Kutsch; Nancy B Spinner; Kristen N Robbins; Veena Venkat; Philip Rosenthal; Joseph Beyene; Alastair Baker; Binita M Kamath Journal: Liver Int Date: 2015-08-18 Impact factor: 5.828
Authors: Mark E Lush; Daniel C Diaz; Nina Koenecke; Sungmin Baek; Helena Boldt; Madeleine K St Peter; Tatiana Gaitan-Escudero; Andres Romero-Carvajal; Elisabeth M Busch-Nentwich; Anoja G Perera; Kathryn E Hall; Allison Peak; Jeffrey S Haug; Tatjana Piotrowski Journal: Elife Date: 2019-01-25 Impact factor: 8.140
Authors: Iris E M de Jong; Alix P M Matton; Jasper B van Praagh; Wouter T van Haaften; Janneke Wiersema-Buist; Louise A van Wijk; Dorenda Oosterhuis; Raditya Iswandana; Su Suriguga; Diletta Overi; Ton Lisman; Guido Carpino; Annette S H Gouw; Peter Olinga; Eugenio Gaudio; Robert J Porte Journal: Hepatology Date: 2019-03-05 Impact factor: 17.425